Titles: H.R.2374 — 116th Congress (2019-2020)All Information (Except Text)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.